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 INTRODUCTION 
 West Nile virus (WNV; family Flaviviridae, genus  Flavivirus ) 
is endemic in much of the United States, 1 and birds played a 
pivotal role in its rapid geographic expansion and establish-
ment. 2–5 Since its arrival to the Western Hemisphere, WNV has 
caused mortality of many thousands of birds, 6 whereas survi-
vors overcome infection and produce anti-WNV antibodies. 7 
West Nile virus seroprevalence rates of various avian species 
have been documented within numerous regions of the United 
States, 8–12 whereas antibody duration has been assessed in cap-
tive birds. 13–15 
 The level of protection provided by primary immunity to 
WNV over multiple transmission seasons has yet to be charac-
terized in birds. This information is important for understand-
ing transmission dynamics, and long-term effects of WNV on 
avian populations. In addition, data regarding long-term dura-
tion of antibodies and response to secondary exposure in a 
variety of avian species will aid in understanding the epide-
miology and ecology of WNV and in interpretation of sero-
survey data. Naturally induced WNV neutralizing antibodies 
were detectable and showed relatively little variation over 
~1 year in rock pigeons ( Columba livia ) and fish crows ( Corvus 
ossifragus ), and > 4 years in raptors. 13–15 
 We performed a 36-month controlled study of WNV infec-
tion in the house sparrow ( Passer domesticus ), an abundant 
and ubiquitous passerine that is a competent reservoir host of 
WNV. 11,16 Our major objectives were to monitor WNV neutral-
izing antibody titers of experimentally inoculated house spar-
rows for up to 36 months, to assess the protectiveness of these 
antibodies over time, and to measure serologic responses to 
primary and secondary exposure. Secondary objectives were 
to assess for contact transmission among communally housed 
sparrows, to compare mortality rates in sparrows caged and 
handled through the period of acute WNV infection with rates 
in sparrows in a free-flight aviary and not captured, and to 
compare viremic responses and viral titers in tissues of birds 
that succumb with those that survive infection. 
 METHODS 
 House sparrow capture and husbandry.  From January to 
March of 2005, 179 adult house sparrows (hereafter, sparrows) 
were captured by mist net in northern Colorado. Upon arrival, 
birds were leg-banded, weighed, and bled from the jugular vein. 
 Sparrows were housed free-flight, divided equally between 
two rooms (each 3.7 m width × 3.7 m height × 5.5 m length) con-
taining branches, stumps, ropes, sand baths, cuttlefish bone, and 
multiple food and water stations. Fresh water and food were 
provided  ad libitum ; food consisted of a dry mix of millet, milo, 
cracked corn, cracked sunflower seed, and oats (in equal parts), 
as well as live mealworms 1–2 times/week. Birds were accli-
mated to captivity for 2–12 weeks before WNV inoculation. 
Birds caged for daily bleedings were housed 2–5 individuals per 
cage (each 0.4–0.5 m width × 0.4 m height × 0.6–0.8 m length). 
 Birds exhibiting clinical signs (lethargy, fluffed feath-
ers, anorexia) before or during the study were euthanized 
via sodium pentobarbital overdose administered intrave-
nously. This study was performed in accordance with regula-
tions established by the Institutional Animal Care and Use 
Committee at Colorado State University. 
 Experimental groups and inoculation.  Sparrows were 
divided into three experimental groups based on initial WNV 
serostatus ( Figure 1 ). Groups included WNV seronegative 
birds for experimental inoculation (hereafter, deemed “exper-
imentally immune;”  N = 114), naturally infected birds with 
pre-existing anti-WNV antibodies (hereafter, deemed “nat-
urally immune;”  N = 21), and WNV seronegative birds to 
serve as antibody-negative controls (hereafter, deemed “non-
immune;”  N = 20). The former two groups were experimentally 
inoculated subcutaneously with 1,000–2,000 plaque forming 
units (PFU) of WNV strain NY99-4132 administered in 0.1 mL 
BA1 (M199-Hank’s salts, 1% bovine serum albumin, 350 mg/L 
sodium bicarbonate, 100 units/mL penicillin, 100 μg/mL strep-
tomycin, 2.5 μg/mL amphotericin B in 0.05 M Tris, pH 7.6). 
The latter group was not experimentally inoculated with the 
initial groups but remained among the inoculated birds as 
non-immune contact controls in the free-flight room to assess 
for potential contact transmission. Some of these seronegative 
sparrows were housed in separate cages from experimentally 
immune sparrows and inoculated as non-immune controls at 
6, 12, 24, and 36 months post-inoculation (PI). 
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 Sample collection and preparation.  After initial inocula-
tion, all but 14 sparrows were housed free-flight within rooms. 
These 14 sparrows (seven naturally immune and seven non-
immune) were caged and bled 0.1 mL via jugular venipunc-
ture from 1 to 6 days PI and then released into the room with 
the remainder of the sparrows. 
 All sparrows were caught by hand-held nets and bled 0.2 mL 
via jugular venipuncture at 1, 6, 12, 18, 24, 30, and 36 months 
PI. At 6 months PI the 21 naturally immune sparrows that had 
been inoculated 6 months prior were bled and euthanized. 
 Challenge experiments (i.e., re-inoculation or secondary 
exposure) occurred at 6, 12, 24, and 36 months PI. Sparrows 
were placed into cages for several days and then needle-
inoculated subcutaneously with 2,500–3,500 PFU of 
WNV strain NY99-4132. After challenge inoculation (or ini-
tial inoculation for non-immune controls), blood samples 
were collected from 1–7 and on 14 days PI, when birds were 
euthanized. 
 Blood samples were either added to BA1 with 20% fetal 
bovine serum (FBS) in cryovials for an approximate 1:10 
serum dilution (for viremia analysis) or dispensed undiluted 
into serum separator tubes (for antibody analysis). Blood 
samples were held at room temperature for 20–30 minutes for 
coagulation, centrifuged for 10 minutes at 6,000 × G and sera 
frozen to −80°C (diluted samples) or for 3 minutes at 12,000 × 
G and sera frozen to −20°C (undiluted samples). 
 Sparrows that died or were euthanized as a result of mor-
bidity < 10 days PI, any non-immune controls that succumbed 
during the study, and eight non-immune controls euthanized at 
14 days PI were necropsied, at which time oropharyngeal swabs, 
spleen, kidney, heart, and brain were collected and placed in 
1 mL BA1 with 20% FBS (tissues were weighed for a 10% sus-
pension). Tissues were processed as previously described 17 and 
tested for WNV by plaque assay. These birds were considered 
to have experienced acute WNV-associated mortality if WNV 
was isolated from multiple tissues. 
 Vero cell plaque assay and plaque reduction neutralization 
test.  Sera collected from 1 to 7 days PI, as well as oral swabs 
and tissue homogenates from birds dying < 10 days PI, were 
tested for infectious WNV by Vero cell plaque assay as pre-
viously described. 18 Representative plaques were confirmed 
as WNV through reisolation and testing by VecTest WNV 
Antigen Assay (Medical Analysis Systems, Camarillo, CA) 
as previously described. 17 The detection thresholds for WNV 
were 10 1.7 PFU/mL serum and 10 0.7 PFU/swab or mL of tissue 
homogenate. 
 Sera were tested for neutralizing antibodies to WNV using 
the plaque reduction neutralization test (PRNT) 19 with the 
same WNV strain as for inoculation of sparrows. Sera that 
neutralized ≤ 60% of WNV PFU were considered negative for 
antibodies, whereas sera that neutralized > 90% were consid-
ered positive (no serum samples neutralized between 60–90% 
of viral plaques). Antibody positive serum samples were seri-
ally diluted 2-fold and tested in duplicate to determine recipro-
cal endpoint 90% neutralization (PRNT 90 ) titers. Anamnestic 
antibody responses to challenge were considered significant 
when a ≥ 4-fold increase in PRNT 90 titer was observed within 
~2–4 weeks of challenge. 
 Mathematical and statistical analyses.  To assess the varia-
tion in PRNT 90 titers of all sparrows alive for at least two con-
secutive time points, the multiple-fold change in titer for each 
individual at a given time point and the one immediately fol-
lowing was represented by a numerical value (e.g., −2 for a 
2-fold decrease, 0 for no change in titer, 2 for a 2-fold increase). 
These values were averaged among all individuals to deter-
mine average changes in titer at each time period ( Table 1 ). 
This analysis avoided eliminating individuals that were not 
present throughout all time points. 
 A χ 2 test (α = 0.05) was used to compare mortality rates (as 
proportions) of caged sparrows that were frequently captured 
and sampled with those of free-flight sparrows not handled 
after inoculation. Peak viremia titers in log 10 PFU/mL serum 
(the dependent variable) were analyzed as a function of dispo-
sition (death versus survival; the fixed variable) using general 
 Figure 1.  Timeline of West Nile virus experimental inocula-
tion of three experimental groups of house sparrows. * Antibody 
(Ab) titer indicates when serum samples were titrated to determine 
WNV PRNT 90 antibody titers. † All birds were bled at 1 month post-
 inoculation to confirm seroconversion and assess antibody titers. 
 Table 1 
 Antibody profiles over time in house sparrows after experimental inoculation with West Nile virus 
Time post-inoculation (months)
1 6 12 18 24 30 36
 N* 104 100 82 69 65 45 42
PRNT 90 range; 
median, mode 40–2,560; 320, 320 10–2,560; 160, 80 < 10–320; 80, 80 10–640; 80, 80 20–1,280; 160, 160 10–640; 80, 40 10–640; 80, 80
PRNT 90 from 20–160 26.9% (28/104) 62.0% (62/100) 79.3% (65/81) 84.1% (58/69) 81.5% (53/65) 86.7% (39/45) 85.7% (36/42)
Overall change in 
PRNT 90 † – −4.7 −2.4 0.0 1.1 −1.6 0.3
 *  N represents the number of sparrows still alive during each time point and included in plaque reduction neutralization test PRNT 90 analyses. 
 † The overall change in PRNT 90 reflects the number-fold increase or decrease in titer from the closest previous time point to the current time point. 
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linear model procedure (Proc GLM). This method was also 
used to compare tissue titers in log 10 PFU/0.5 cm 
3 (the depen-
dent variable), analyzed as a function of days PI when death 
occurred (5–6 days PI versus 7–9 days PI; the fixed variable). 
Viral titers below the threshold of detection were considered 
zero. Statistics were calculated in SAS/STAT MULTTEST 
software, version 9.1 (SAS Institute, Inc., Cary, NC). 
 RESULTS 
 Initial serology and mortality.  Thirty-one of 179 (17.3%) 
free-ranging sparrows had WNV-neutralizing antibodies 
before initiation of the study. A total of 125 seronegative spar-
rows were inoculated (114 at initiation of the study, plus 11 
controls during subsequent challenge time points), 14 of which 
experienced acute WNV-associated mortality after experi-
mental inoculation. An additional 32 deaths occurred over 
the 36-month study, including four seronegative control birds. 
Twelve experimentally immune sparrows were euthanized at 
pre-determined time points for a separate study. All deaths 
that occurred beyond the acute phase of infection were attrib-
uted to natural causes, bird-induced trauma, or husbandry- or 
sampling-related causes. 
 Contact transmission.  No serologic evidence of contact 
transmission was observed in non-immune control sparrows 
( N = 20) throughout the study. Ten of these were alive at 36 
months PI, six were euthanized during challenge experiments, 
and four died during the study (the latter had no evidence of 
acute WNV infection). 
 Acute responses to infection in non-immune sparrows. 
 After inoculation with WNV, a total of 18 non-immune spar-
rows were caged and bled daily to evaluate viremia, whereas 
107 birds were released into large rooms and not handled until 
1 month PI. Five of 18 (27.8%) caged sparrows had visible clin-
ical signs after inoculation, including lethargy, fluffed feathers, 
anorexia, and/or hind limb rigidity; these birds died or were 
euthanized between 5–9 days PI. Mortality attributed to WNV 
infection (death at < 10 days PI and WNV isolated from mul-
tiple tissues) was significantly greater among the caged spar-
rows handled daily (5/18; 27.8%) compared with free-flying 
sparrows that were not handled (9/107; 8.4%) ( N = 125, χ 2 = 
5.81,  P = 0.016; 95% confidence interval [CI]: 0.069, 0.823). 
 All 18 non-immune control sparrows caged and bled 
daily after inoculation developed viremia of ≥ 3 days dura-
tion. The peak viremia titers of sparrows that experienced 
WNV-associated morbidity and mortality (10 5.5–10.2 PFU/mL 
serum; mean 10 9.7 ) were significantly higher than in those 
that survived acute infection and showed no clinical signs 
(10 4.5–7.6 PFU/mL serum; mean 10 6.6 ) ( N = 18,  P = 0.006, 95% 
CI: 0.694, 3.401) ( Figure 2 ). Death occurred from 1 to 6 days 
after peak viremia, and viremia titers decreased ~200–300,000-
fold before death in 4/5 (80.0%) sparrows. 
 All of 14 necropsied sparrows that died of acute infec-
tion had WNV isolated from oropharyngeal swab (10 2.2–6.6 
PFU/swab), heart (10 1.7–6.5 PFU/0.5 cm 3 ), and kidney (10 0.7–7.1 
PFU/0.5 cm 3 ); 13/14 (92.9%) also had virus isolated from brain 
(10 4.2–6.7 PFU/0.5 cm 3 ) and 12/14 (85.7%) from spleen (10 3.8–7.1 
PFU/0.5 cm 3 ). Viral titers in all tissues were significantly higher 
in birds that succumbed to acute infection earlier (5–6 days PI) 
versus after this time ( N = 14; oropharyngeal swab,  P = 0.014, 
95% CI: 0.380, 2.778; heart,  P < 0.001, 95% CI: 1.394, 3.610; kid-
ney,  P < 0.001, 95% CI: 2.822, 5.120; spleen,  P = 0.001, 95% CI: 
1.863, 5.573; brain,  P = 0.006, 95% CI: 0.903, 4.206). West Nile 
virus was isolated from tissues collected from three of eight 
necropsied individuals that remained healthy until euthanasia 
at 14 days PI (spleen from two individuals at 10 1.3–2.0 PFU/cm 3 , 
and kidney 10 1.0 PFU/0.5 cm 3 and heart 10 0.7 PFU/0.5 cm 3 from 
another individual). 
 Acute responses to challenge in immune sparrows.  All 
but one of 71 (98.6%) house sparrows challenged by needle-
inoculation at 6–36 months PI demonstrated sterilizing 
immunity; one sparrow had low-titered viremia from 3 to 5 
days after challenge ( Table 2 ). Antibody titers in this bird 
increased 256-fold by 14 days post-challenge. Anamnestic 
rises in antibody titers of ≥ 4-fold by 14 days post-challenge 
were observed in 72.9% (51/70) of experimentally immune 
sparrows, and rises were pronounced in some cases (up to 
512-fold). 
 Figure 2.  Average daily viremia titers among house sparrows 
experimentally inoculated with West Nile virus that succumbed and 
those that survived infection. Standard error bars are provided for 1–6 
days post-inoculation. 
 Table 2 
 Serologic responses among immune and non-immune house sparrows after experimental inoculation with West Nile virus 
Pre-inoculation Viremia profiles 14 days post-inoculation
Experimental group, time PI*  N PRNT 90 † range % viremic Peak range (PFU‡/mL serum) PRNT 90 titer range % ≥ 4-fold increase
Non-immune controls 18 < 10 100 10 4.5–10.2 40–2,560 –
Naturally- immune 7 10–320 0 < 10 1.7 80–2,560§ 38
Experimentally immune, 6 mo PI 10 10–80 10 10 1.7–2.4 80–2,560 80
Experimentally immune, 12 mo PI 10 < 10–80 0 < 10 1.7 20–2,560 80
Experimentally immune, 24 mo PI 10 10–320 0 < 10 1.7 40–2,560 60
Experimentally immune, 36 mo PI 41 10–640 0 < 10 1.7 80–20,480 73
 *  PI = post-inoculation. 
 † PRNT 90 = endpoint 90% neutralization titer (PRNT 90 < 10 is considered seronegative). 
 ‡ PFU = plaque forming units. 
 § Post-inoculation PRNT 90 titers for the naturally immune group were determined at one month PI, and 21 birds were included in this analysis. 
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 No experimentally immune sparrows exhibited morbid-
ity or mortality after challenge except for one bird that died 
5 days post-36-month challenge. This individual had no detect-
able viremia after challenge, and heart, spleen, brain, and 
kidney were negative by virus isolation, though a low titer 
(10 1.7 PFU/swab) of infectious WNV was isolated from the 
oropharyngeal swab collected after death. 
 None of the naturally immune sparrows ( N = 21) exhibited 
morbidity or mortality after challenge inoculation, and none 
of the seven sparrows bled from 1 to 6 days after challenge 
inoculation had detectable viremia. 
 Chronic responses to challenge in immune sparrows.  All 
non-immune sparrows that survived inoculation serocon-
verted and 55% (55/100) had a ≥ 4-fold decrease in anti-
body titer from 1 to 6 months PI. Thereafter, little variation in 
PRNT 90 titers was observed ( Table 1 ), as titers of most spar-
rows (41/42; 97.6%) did not vary ≥ 2-fold over the subsequent 
30 months. 
 Approximately 38% (8/21) of naturally immune sparrows 
exhibited a ≥ 4-fold increase in PRNT 90 antibody titer 1 month 
after challenge ( Table 2 ). At 6 months PI, titers ranged from 40 
to 1,280, with 19.0% (4/21) exhibiting a ≥ 4-fold decrease from 
1 to 6 months post-challenge. 
 DISCUSSION 
 An understanding of the duration and protection provided 
by WNV immunity in passerine birds is important because 
numerous members of this large taxonomic group are virus-
amplifying hosts 20 that are commonly fed upon by mosqui-
toes. 21–23 Some passerines, such as the house sparrow, reside 
primarily or exclusively in areas where humans are pres-
ent, 16 suggesting that their WNV reservoir competence and 
immune responses could have implications for public health. 11 
Although many passerines experience relatively high vire-
mia titers after WNV infection, some also mount an effec-
tive immune response and survive infection. 8–11,20 In addition, 
WNV immunity is long-lasting in some birds. 13–15 However, 
the ability of anti-WNV antibodies to protect against viremia 
upon subsequent infection in birds, thereby effectively render-
ing a potential amplifying host into a dead-end host, remains 
unknown. 
 Elevated WNV transmission likely corresponds to relatively 
high proportions of infected birds, and the resulting wide-
spread immunity among survivors could potentially dampen 
transmission. 24 If immune birds survive multiple transmis-
sion seasons and their immunity persists, the protective effect 
against infection among the remainder of the population (e.g., 
herd immunity) may be relatively long-lasting and lead to a 
reduction in disease incidence. 13,25 Humans and other verte-
brates may also benefit from long-lasting protective WNV 
immunity among birds. Annual adult survival of house spar-
rows is 57% and longevity has reached > 13 years in the wild. 16 
In addition, house sparrows were recaptured after an average 
of 559 days (range 502–649) in southern California, 26 support-
ing the notion that some free-ranging sparrows survive mul-
tiple transmission seasons. However, herd immunity may be 
unattainable in some avian species based on life history traits 
such as population turnover rate and life span. For example, 
the house sparrow often rears multiple broods of up to eight 
chicks per brood in a given season, leading to an influx of naive 
offspring into the population at regular intervals. Furthermore, 
annual survival of hatch-year house sparrows is estimated at 
only 20%. 16 Collectively, these factors may make it difficult to 
attain a sufficient proportion of immune individuals to protect 
the remainder of the population. 
 Along with duration, the level of protection provided by 
anti-WNV antibodies affects transmission dynamics and avian 
population health. Antibodies to other flaviviruses for which 
birds also serve as amplifying hosts, such as St. Louis encepha-
litis virus (SLEV), have variable persistence in birds, some-
times declining after 3 months PI and becoming undetectable 
by 6–12 months PI. However, even with undetectable SLEV-
neutralizing antibodies, some experimentally inoculated 
house finches ( Carpodacus mexicanus ) and house sparrows 
were protected from viremia at 6, 12, and 24 months PI with 
anamnestic rises in titers in those challenged at 12 months 
PI. 24,27,28 In the present study, nearly all sparrows were pro-
tected from challenge for up to 36 months PI, as evidenced 
by sterilizing immunity. The significance of the single experi-
mentally immune house sparrow that experienced a relatively 
low-titered viremia after challenge is unknown, but this bird 
apparently retained partial immunity, resulting in titers below 
those observed in non-immune sparrows. West Nile virus was 
unlikely associated with the death of one experimentally 
immune sparrow after challenge inoculation because of a lack 
of virus detection in serum and tissues. However, low levels of 
virus were detected in the oropharyngeal cavity upon death, 
the significance of which is also unknown. 
 Understanding patterns of anamnestic antibody responses 
subsequent to initial infection in birds is useful for interpre-
tation of serosurveillance and diagnostic data. Traditionally, 
a ≥ 4-fold increase in antibody titer over several weeks to 
months indicates a recent infection. 19 However, in the present 
study, ~27% of experimentally immune and ~62% of naturally 
immune sparrows failed to meet this criterion. Similarly, 5/6 
(83.3%) SLEV-immune house finches failed to demonstrate 
a > 2-fold rise in anti-SLEV antibody titer 2 and 6 weeks after 
homologous challenge; however, all of four WNV-immune 
finches exhibited a ≥ 4-fold increase in anti-WNV antibody 
titer when challenged with WNV. 7 Perhaps in some cases, exist-
ing immunity is sufficient to neutralize challenge virus or rises 
in post-challenge titers are delayed. Alternately, needle-inoc-
ulation could fail to stimulate a rise in antibody titer, though 
needle versus mosquito inoculation did not lead to a differ-
ence in overall patterns of arbovirus infection observed in 
chickens or house finches. 29,30 In the present study, most house 
sparrows experienced a ≥ 4-fold decrease in antibody titer 
between 1 and 6 months PI, likely reflecting a decline after the 
initial peak that follows primary infection, a pattern that may 
suggest relatively recent WNV infection in some birds. 14 
 The significance and extent of bird-to-bird WNV transmis-
sion in nature remains unknown, but the probability of con-
tact transmission is likely dependent upon multiple factors, 
such as bird behavior, habitat, and environmental conditions. 
Although bird-to-bird WNV transmission has been observed 
in corvids, gulls, and domestic birds in controlled experi-
ments, 20,31–33 no house sparrows in the present study became 
infected through contact transmission. Unlike most previ-
ous studies, in which birds were caged, housing in the present 
study was more similar to a natural setting, consisting of spa-
cious rooms with hundreds of perching options and numer-
ous food and water stations. The likelihood and frequency of 
bird-to-bird WNV transmission in nature remain unknown. 
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 Much of the currently available information regarding 
avian mortality rates associated with North American strains 
of WNV derives from experimental infection studies involv-
ing wild-caught birds subsequently caged and frequently han-
dled for sampling. These birds likely undergo intensified and 
frequent rises in stress levels because of confinement and 
repeated close contact and handling by humans that differ 
from the more prolonged and continual stress associated with 
life in the wild to which they are presumably more accustomed 
(e.g., underlying competition for food and territories, constant 
need for foraging and vigilance against predators, unfavor-
able climate, etc.). Thus, captive studies may lead to overes-
timates of WNV-attributed morbidity and mortality rates in 
free- ranging birds. Mortality rates of caged house sparrows 
bled daily after experimental inoculation with WNV NY99 
have ranged from ~38 to 50%. 20,34 In the present study, the 
mortality rate of caged birds handled daily was significantly 
higher than that observed among birds in a free-flight aviary 
and spared the stress of capture, restraint, and blood collection 
(27.8  versus 7.5%, respectively). 
 Although marked differences in responses to WNV infec-
tion among North American bird species have been observed, 20 
intra-species differences suggest that individual variation is 
also an important factor in infection outcome. Results from 
the present study suggest that individuals that are unable to 
control viral replication in tissues, including blood, are less 
likely to recover from infection. Some sparrows succumbed to 
infection near the period of peak viremia, whereas others suc-
cumbed up to 6 days after viremia titers began to decline. This 
inability to control virus replication and dissemination may be 
associated with immune deficiencies, as was observed in anti-
body, IgM, and B cell-deficient mice that had higher viremia 
titers, higher viral loads in the central nervous system, and 
were more vulnerable to lethal WNV infection than wild-type 
mice. 35,36 However, some birds that succumb to WNV infection 
begin to mount WNV-neutralizing antibody responses prior to 
death. 37 Studies are needed that examine the potential under-
lying immune deficits that may be associated with higher vire-
mia titers, widespread viral dissemination, and eventual death 
in birds. 
 In conclusion, successful transmission of WNV in nature is 
dependent upon avian amplifying hosts. Therefore, knowledge 
of patterns of immunity in birds will aid in understanding and 
predicting future transmission patterns. Long-lasting protec-
tive immunity to WNV infection in birds could potentially 
dampen transmission rates both within bird populations, and 
in humans and other susceptible vertebrates. 
 Received December 14, 2008. Accepted for publication February 12, 
2009. 
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